ARCHIVES

Nobel Laureate Gilman Prepares to Leave The Texas Cancer Agency—Can it Survive?

This article is from The Cancer Letter archive.

Vol. 38 No. 36 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

Acting Commissioner Tells Grassley He Supports “Academic Freedom” at The Agency, but “At A Proper Time.”

December 1, 2006

Clinical trials: ORI Cites Data Manager For Misconduct; Results Not Affects, NCI Says

April 2, 1999

AHCPR Funds Centers to Review Practice

July 4, 1997

Study Validates “PEM” Scans As Biopsy Guidance Method

April 29, 2011

NTP Board Okays concept for New In Vitro study Using Oncogenes

May 10, 1985

Cancer Policy: Board Plans Paper On Tobacco Control

June 13, 1997